BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 121 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2018. The put-call ratio across all filers is 0.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $101,473,000 | +1291.9% | 696,402 | +1032.8% | 0.06% | +1475.0% |
Q1 2022 | $7,290,000 | +16.9% | 61,476 | +35.9% | 0.00% | +33.3% |
Q4 2021 | $6,235,000 | -25.9% | 45,244 | -25.3% | 0.00% | -40.0% |
Q3 2021 | $8,415,000 | +556.4% | 60,579 | +358.9% | 0.01% | +400.0% |
Q2 2021 | $1,282,000 | -65.0% | 13,200 | -75.4% | 0.00% | -66.7% |
Q1 2021 | $3,665,000 | -53.6% | 53,616 | -41.8% | 0.00% | -50.0% |
Q4 2020 | $7,895,000 | +754.4% | 92,113 | +547.9% | 0.01% | +500.0% |
Q3 2020 | $924,000 | -38.6% | 14,217 | -30.9% | 0.00% | -50.0% |
Q2 2020 | $1,505,000 | +12.2% | 20,579 | -47.8% | 0.00% | -33.3% |
Q1 2020 | $1,341,000 | -85.5% | 39,400 | -76.7% | 0.00% | -72.7% |
Q4 2019 | $9,219,000 | +182.6% | 169,343 | +127.3% | 0.01% | +120.0% |
Q2 2019 | $3,262,000 | -28.9% | 74,490 | -16.5% | 0.01% | -28.6% |
Q1 2019 | $4,590,000 | +207.0% | 89,180 | +120.5% | 0.01% | +250.0% |
Q4 2018 | $1,495,000 | +10.7% | 40,439 | +12.4% | 0.00% | 0.0% |
Q3 2018 | $1,351,000 | -70.5% | 35,991 | -68.9% | 0.00% | -66.7% |
Q2 2018 | $4,572,000 | +46.7% | 115,691 | -4.4% | 0.01% | +50.0% |
Q1 2018 | $3,116,000 | -58.2% | 120,979 | -56.2% | 0.00% | -60.0% |
Q4 2017 | $7,459,000 | – | 276,450 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |